A citation-based method for searching scientific literature

Marwa Mohsen, Ahmed A Elberry, Alaa Mohamed Rabea, Mohamed E A Abdelrahim, Raghda R S Hussein. Int J Clin Pract 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Plasma levels of DPP4 activity and sDPP4 are dissociated from inflammation in mice and humans.
Laurie L Baggio, Elodie M Varin, Jacqueline A Koehler, Xiemin Cao, Yuliya Lokhnygina, Susanna R Stevens, Rury R Holman, Daniel J Drucker. Nat Commun 2020
15
100

Randomized trial of an intensified, multifactorial intervention in patients with advanced-stage diabetic kidney disease: Diabetic Nephropathy Remission and Regression Team Trial in Japan (DNETT-Japan).
Kenichi Shikata, Masakazu Haneda, Toshiharu Ninomiya, Daisuke Koya, Yoshiki Suzuki, Daisuke Suzuki, Hitoshi Ishida, Hiroaki Akai, Yasuhiko Tomino, Takashi Uzu,[...]. J Diabetes Investig 2021
4
100

Renoprotective effect of DPP-4 inhibitors against free fatty acid-bound albumin-induced renal proximal tubular cell injury.
Yuki Tanaka, Shinji Kume, Masami Chin-Kanasaki, Hisazumi Araki, Shin-Ichi Araki, Satoshi Ugi, Takeshi Sugaya, Takashi Uzu, Hiroshi Maegawa. Biochem Biophys Res Commun 2016
31
100

Effect of sitagliptin on tubulointerstitial Wnt/β-catenin signalling in diabetic nephropathy.
Xiaojun Ren, Ruifang Zhu, Gaohong Liu, Fuping Xue, Yanhong Wang, Jia Xu, Wan Zhang, Weimin Yu, Rongshan Li. Nephrology (Carlton) 2019
4
100

A Dipeptidyl Peptidase-4 Inhibitor, Teneligliptin, Decreases Plasma Triglyceride-Rich Lipoprotein Remnants in Diabetic Patients with Chronic Kidney Disease Undergoing Hemodialysis.
Koichiro Homma, Joe Yoshizawa, Yutaka Shiina, Hideki Ozawa, Muneki Igarashi, Tadashi Matsuoka, Junichi Sasaki, Mamoru Yoshizawa, Yasuhiko Homma. Drugs R D 2017
5
100

Role of linagliptin in preventing the pathological progression of hepatic fibrosis in high fat diet and streptozotocin-induced diabetic obese rats.
Yara M Aboulmagd, Alshaymaa A Z El-Bahy, Esther T Menze, Samar S Azab, Ebtehal El-Demerdash. Eur J Pharmacol 2020
2
100

Unraveling the Role of Inflammation in the Pathogenesis of Diabetic Kidney Disease.
Keiichiro Matoba, Yusuke Takeda, Yosuke Nagai, Daiji Kawanami, Kazunori Utsunomiya, Rimei Nishimura. Int J Mol Sci 2019
51
100

Activation of the Nrf2-ARE pathway attenuates hyperglycemia-mediated injuries in mouse podocytes.
Cheng Wang, CuiCui Li, Hui Peng, Zengchun Ye, Jun Zhang, Xun Liu, Tanqi Lou. Cell Physiol Biochem 2014
24
100



Effect of Linagliptin on Structural Changes in the Kidney in Experimental Type 2 Diabetes Mellitus.
Yu S Gavrilova, N P Bgatova, V V Klimontov, I Yu Ischenko, S V Michurina, N E Myakina, E L Zavyalov. Bull Exp Biol Med 2016
5
100

Sitagliptin prevents inflammation and apoptotic cell death in the kidney of type 2 diabetic animals.
Catarina Marques, Cristina Mega, Andreia Gonçalves, Paulo Rodrigues-Santos, Edite Teixeira-Lemos, Frederico Teixeira, Carlos Fontes-Ribeiro, Flávio Reis, Rosa Fernandes. Mediators Inflamm 2014
80
100

Signaling pathways in diabetic nephropathy.
Daiji Kawanami, Keiichiro Matoba, Kazunori Utsunomiya. Histol Histopathol 2016
48
100

Renal and intestinal absorptive defects in mice lacking the NHE3 Na+/H+ exchanger.
P J Schultheis, L L Clarke, P Meneton, M L Miller, M Soleimani, L R Gawenis, T M Riddle, J J Duffy, T Doetschman, T Wang,[...]. Nat Genet 1998
611
100

ROCK2 regulates TGF-β-induced expression of CTGF and profibrotic genes via NF-κB and cytoskeleton dynamics in mesangial cells.
Yosuke Nagai, Keiichiro Matoba, Daiji Kawanami, Yusuke Takeda, Tomoyo Akamine, Sho Ishizawa, Yasushi Kanazawa, Tamotsu Yokota, Kazunori Utsunomiya, Rimei Nishimura. Am J Physiol Renal Physiol 2019
22
100

Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes.
Muralikrishna Gangadharan Komala, Simon Gross, Amgad Zaky, Carol Pollock, Usha Panchapakesan. Nephrology (Carlton) 2016
45
100


Glomerular endothelial cell injury and cross talk in diabetic kidney disease.
Jia Fu, Kyung Lee, Peter Y Chuang, Zhihong Liu, John Cijiang He. Am J Physiol Renal Physiol 2015
124
100


Stromal cell-derived factor-1 is upregulated by dipeptidyl peptidase-4 inhibition and has protective roles in progressive diabetic nephropathy.
Satoru Takashima, Hiroki Fujita, Hiromi Fujishima, Tatsunori Shimizu, Takehiro Sato, Tsukasa Morii, Katsushi Tsukiyama, Takuma Narita, Takamune Takahashi, Daniel J Drucker,[...]. Kidney Int 2016
62
100

A role for NPY-NPY2R signaling in albuminuric kidney disease.
Abigail C Lay, A Fern Barrington, Jenny A Hurcombe, Raina D Ramnath, Mark Graham, Philip A Lewis, Marieangela C Wilson, Kate J Heesom, Matthew J Butler, Rebecca M Perrett,[...]. Proc Natl Acad Sci U S A 2020
3
100

Neuropeptide Y Is an Immunomodulatory Factor: Direct and Indirect.
Wei-Can Chen, Yi-Bin Liu, Wei-Feng Liu, Ying-Ying Zhou, He-Fan He, Shu Lin. Front Immunol 2020
14
100

Sitagliptin reduces the urine albumin-to-creatinine ratio in type 2 diabetes through decreasing both blood pressure and estimated glomerular filtration rate.
Isao Kawasaki, Yoshikazu Hiura, Anna Tamai, Yoko Yoshida, Yosuke Yakusiji, Yoshiko Ikuno, Megumi Okada, Hiroki Ueno, Nagaaki Tanaka, Keiko Yamagami,[...]. J Diabetes 2015
30
100

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, P Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Robert Frederich, Stephen D Wiviott, Elaine B Hoffman,[...]. N Engl J Med 2013
100


Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes.
Ryo Kodera, Kenichi Shikata, Tetsuharu Takatsuka, Kaori Oda, Satoshi Miyamoto, Nobuo Kajitani, Daisho Hirota, Tetsuichiro Ono, Hitomi Kataoka Usui, Hirofumi Makino. Biochem Biophys Res Commun 2014
67
100

Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes.
Y-S Lee, M-S Park, J-S Choung, S-S Kim, H-H Oh, C-S Choi, S-Y Ha, Y Kang, Y Kim, H-S Jun. Diabetologia 2012
137
100

Sitagliptin improves albuminuria in patients with type 2 diabetes mellitus.
Hiroko Mori, Yosuke Okada, Tadashi Arao, Yoshiya Tanaka. J Diabetes Investig 2014
66
100

Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition.
Sen Shi, Swayam Prakash Srivastava, Megumi Kanasaki, Jianhua He, Munehiro Kitada, Takako Nagai, Kyoko Nitta, Susumu Takagi, Keizo Kanasaki, Daisuke Koya. Kidney Int 2015
96
100

An Overview of Nrf2 Signaling Pathway and Its Role in Inflammation.
Sarmistha Saha, Brigitta Buttari, Emiliano Panieri, Elisabetta Profumo, Luciano Saso. Molecules 2020
73
100




Protein kinase C and protein kinase A are involved in the protection of recombinant human glucagon-like peptide-1 on glomeruli and tubules in diabetic rats.
Weiqin Yin, Yongwei Jiang, Shiqing Xu, Zai Wang, Liang Peng, Qing Fang, Tingting Deng, Wanni Zhao, Wenjian Zhang, Jinning Lou. J Diabetes Investig 2019
7
100

Dipeptidyl peptidase IV inhibitor attenuates kidney injury in streptozotocin-induced diabetic rats.
Wei Jing Liu, Shu Hua Xie, Yu Ning Liu, Won Kim, Heung Yong Jin, Sung Kwang Park, Yi Ming Shao, Tae Sun Park. J Pharmacol Exp Ther 2012
164
100

Alogliptin after acute coronary syndrome in patients with type 2 diabetes.
William B White, Christopher P Cannon, Simon R Heller, Steven E Nissen, Richard M Bergenstal, George L Bakris, Alfonso T Perez, Penny R Fleck, Cyrus R Mehta, Stuart Kupfer,[...]. N Engl J Med 2013
100


Erythropoiesis-stimulating agent slows the progression of chronic kidney disease: a possibility of a direct action of erythropoietin.
Kazuhiko Tsuruya, Hisako Yoshida, Takaichi Suehiro, Kiichiro Fujisaki, Kosuke Masutani, Takanari Kitazono. Ren Fail 2016
9
100


Mechanisms of GLP-1 receptor-independent renoprotective effects of the dipeptidyl peptidase type 4 inhibitor linagliptin in GLP-1 receptor knockout mice with 5/6 nephrectomy.
Ahmed A Hasan, Karoline von Websky, Christoph Reichetzeder, Oleg Tsuprykov, Mohamed M S Gaballa, Jingli Guo, Shufei Zeng, Denis Delić, Harald Tammen, Thomas Klein,[...]. Kidney Int 2019
12
100

Dipeptidyl Peptidase-4 Inhibition With Saxagliptin Ameliorates Angiotensin II-Induced Cardiac Diastolic Dysfunction in Male Mice.
Scott M Brown, Cassandra E Smith, Alex I Meuth, Maloree Khan, Annayya R Aroor, Hannah M Cleeton, Gerald A Meininger, James R Sowers, Vincent G DeMarco, Bysani Chandrasekar,[...]. Endocrinology 2017
14
100


The dipeptidyl peptidase inhibitor linagliptin and the angiotensin II receptor blocker telmisartan show renal benefit by different pathways in rats with 5/6 nephrectomy.
Oleg Tsuprykov, Ryotaro Ando, Christoph Reichetzeder, Karoline von Websky, Viktoriia Antonenko, Yuliya Sharkovska, Lyubov Chaykovska, Jan Rahnenführer, Ahmed A Hasan, Harald Tammen,[...]. Kidney Int 2016
51
100


Natriuretic effect by exendin-4, but not the DPP-4 inhibitor alogliptin, is mediated via the GLP-1 receptor and preserved in obese type 2 diabetic mice.
Timo Rieg, Maria Gerasimova, Fiona Murray, Takahiro Masuda, Tong Tang, Michael Rose, Daniel J Drucker, Volker Vallon. Am J Physiol Renal Physiol 2012
106
100

Dipeptidyl Peptidase 4 Inhibition Stimulates Distal Tubular Natriuresis and Increases in Circulating SDF-1α1-67 in Patients With Type 2 Diabetes.
Julie A Lovshin, Harindra Rajasekeran, Yulyia Lytvyn, Leif E Lovblom, Shajiha Khan, Robel Alemu, Amy Locke, Vesta Lai, Huaibing He, Lucinda Hittle,[...]. Diabetes Care 2017
67
100

Regulation of Dipeptidyl Peptidase-4, its Substrate Chemokines, and Their Receptors in Adipose Tissue of ob/ob Mice.
Jihoon Shin, Atsunori Fukuhara, Toshiharu Onodera, Chieko Yokoyama, Michio Otsuki, Iichiro Shimomura. Horm Metab Res 2017
6
100

DPP4 inhibition attenuates filtration barrier injury and oxidant stress in the zucker obese rat.
Ravi Nistala, Javad Habibi, Annayya Aroor, James R Sowers, Melvin R Hayden, Alex Meuth, William Knight, Tamara Hancock, Thomas Klein, Vincent G DeMarco,[...]. Obesity (Silver Spring) 2014
55
100


Amelioration of Early Markers of Diabetic Nephropathy by Linagliptin in Fructose-Streptozotocin-Induced Type 2 Diabetic Rats.
Mamdouh A Oraby, Mohammed F El-Yamany, Marwa M Safar, Naglaa Assaf, Hamdy A Ghoneim. Nephron 2019
4
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.